The congress will be held at the Congress Center Hamburg (CCH) in Germany on 6 to 8 April 2016. For the first time, it will feature one or more sessions on medical writing.
Karl Broich, President of the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) in Germany, and Kemal Malik, a member of the board of management at Bayer AG in Germany, will be the co-chairs of the 28th Drug Information Association (DIA) EuroMeeting.
The congress will be held at the Congress Center Hamburg (CCH) in Germany on 6 to 8 April 2016. For the first time, it will feature one or more sessions on medical writing.
The call for abstracts for presentations, full sessions and tutorials is open until 29 June. Applicants may submit more than one abstract, and they should cover innovation, clinical research, clinical trials, regulatory science, medical affairs, eHealth/big data, pharmacovigilance, lifecycle benefit/risk management, availability of medicinal products, globalization, medical devices and combination products, and health tech assessment.
According to a statement on the DIA web site, the main aim of the 2016 EuroMeeting will be “to provide a platform for experts from all relevant disciplines within the entire healthcare development and access process to debate and find solutions to some of the most pertinent challenges faced in an ever-evolving healthcare system - including the need to drive innovation.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.